Transferrin in patients with multiple sclerosis: A comparison among various subgroups of multiple sclerosis patients

Acta Neurologica Scandinavica

Volumn 101, Issue 2, 2000, Pages 89-94

  Zeman, D ^a   Adam, P ^a   Kalistova H ^a   Sobek, O ^a   Kelbich, P ^a   Andel J ^b   Andel M ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Transferrin

Indexed keywords

TRANSFERRIN;

ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CONTROLLED STUDY; FEMALE; HUMAN; IRON METABOLISM; IRON TRANSPORT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; TRANSFERRIN BLOOD LEVEL;

AGE FACTORS; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 0033956043     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101002089.x     Document Type: Article

References (25)

1. 1. De Jong G, Van Dijk JP, Van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;90:1-46.
2. 2. Wick M. Iron metabolism and its disorders. In: Thomas L, ed. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH, 1998:268-73.
3. 3. Lum JB, Infante J, Makker DM, Yang F, Bowman BH. Transferrin synthesis by inducer T lymphocytes. J Clin Invest 1986;77:841-7.
4. R instructions for antiserum use. Orion Diagnostica, 1998.
5. 5. Adam P, Nekola P, Zeman D et al. The assessment of biological behaviour of transferrin in cerebrospinal fluid. Klin Biochem Metabol 1998;6(27):253-7.
6. 6. Weitbrecht WU, Henzi M. Zur Frage der Herkunft und der diagnostichen Bedeutung der Liquor-Beta-Globuline. Fortschr Neurol Psychiatr 1980;48:294-300.
7. 7. Felgenhauer K. Laboratory diagnosis of neurological diseases. In: Thomas L, ed. Clinical Laboratory Diagnostics. Use and assessment of clinical laboratory results. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH, 1998: 1308-26.
8. 8. Tsutsumi M, Skinner MK, Sanders Bush E. Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells. Regulation by serotonin and cyclic adenosine 3′,5′-monophosphate. J Biol Chem 1989;264:9626-31.
9. 9. Ohe Y, Ishikawa K, Itoh Z, Tatemoto K. Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J Neurochem 1996;67:964-71.
10. 10. Bradbury MW. Transport of iron in the blood-brain cerebrospinal fluid system. J Neurochem 1997;69:443-54.
11. 11. Stecher VJ, Thorbecke GJ. Sites of synthesis of serum proteins. I. Serum proteins produced by macrophages in vitro. J Immunol 1967;99:643-52.
12. 12. Crowe A, Morgan EH. Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 1992; 592:8-16.
13. 13. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13,3:227-31.
14. 14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
15. 15. Kerényi L, Koltai M, Szirmai I. CSF transferrins characterized by the transferrin/albumin index. Clin Chim Acta 1980;105:195-9.
16. 16. Baark JP, Berg O, Hemmingsen L. Immunonephelometric determination of proteins in cerebrospinal fluid in various neurological disorders. Clin Chim Acta 1983;127:271-7.
17. 17. LeVine SM, Lynch SG, Ou CN, Wulser MJ, Tam E, Boo N. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999;821:511-15.
18. 18. Forge JK, Pedchenko TV, LeVine SM. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 1998;63:2271-84.
19. 19. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760:298-303.
20. 20. Del Principe D, Menichelli A, Colistra C. The ceruloplasmin and transferrin system in cerebrospinal fluid of acute leukemia patients. Acta Paediatr Scand 1989;78: 327-8.
21. 21. Gutteridge JM. Iron and oxygen: a biologically damaging mixture. Acta Paediatr Scand Suppl 1989;361:78-85.
22. 22. Brock JH. Iron-binding proteins. Acta Paediatr Scand Suppl 1989;361:31-43.
23. 23. Van Kamp GJ, Mulder K, Kuiper M, Wolters EC. Changed transferrin sialylation in Parkinson's disease. Clin Chim Acta 1995;235:159-67.
24. 24. Riise T, Gronning M, Fernández O et al. Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand 1992;85:212-18.
25. 25. Jongen PJH, Lamers KJB, Doesburg WH, Lemmens WAJG, Hommes OR. Cerebrospinal fluid analysis differentiates between relapsing remitting and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:446-51.